Contracts Finder · Award
NHS Framework Agreement - Hepatitis C Medicines
A public procurement published by NHS England via Contracts Finder.
- £180m
- Award value
- £180m
- Tender value
- 4
- Suppliers
- 4
- Awards
- 1
- Notices
- Award
- Stage
Overview
NHS Framework Agreement for Hepatitis C medicines for Midlands & East and North of England regions and NHS Framework Agreement for Hepatitis C Medicines for London and South of England regions Period of framework agreement: CM/PHR/17/5560/01 - Hepatitis C medicines for Midlands & East and North of England - 1 April 2018 - 28 March 2019 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/17/5560/02 - Hepatitis C medicines for Midlands & East and North of England and Hepatitis C Medicines for London and South of England - 1 April 2018 - 28 March 2019 with an option to extend (at the Authority's discretion) for a period or…
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- £180,000,000
- Tender value
- £180,000,000
- First published
- 21 May 2018
- Last updated
- 21 May 2018
Awards
4 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| AbbVie Ltd | 08004972 | 15 Apr 2018 | active | £180m |
| Gilead Sciences Ltd | 02543818 | 15 Apr 2018 | active | £180m |
| Merck Sharp and Dohme Ltd | — | 15 Apr 2018 | active | £180m |
| Roche Products UK Ltd | — | 15 Apr 2018 | active | £180m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
FAQs about this procurement
Who is the buyer for "NHS Framework Agreement - Hepatitis C Medicines"?
NHS Framework Agreement - Hepatitis C Medicines is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "NHS Framework Agreement - Hepatitis C Medicines" been awarded?
Yes — 4 awards are recorded, with a reported total value of £180,000,000. The current lifecycle stage is "Award".
Which suppliers are involved in "NHS Framework Agreement - Hepatitis C Medicines"?
4 suppliers are linked: AbbVie Ltd, Gilead Sciences Ltd, Merck Sharp and Dohme Ltd, Roche Products UK Ltd.
What is "NHS Framework Agreement - Hepatitis C Medicines" worth?
The reported award value is £180,000,000.
When was "NHS Framework Agreement - Hepatitis C Medicines" published?
It was first published on 21 May 2018 and last updated on 21 May 2018, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable